High-purity Enoxaparin Sodium API — GMP Certified
Enoxaparin Sodium is a low molecular weight heparin (LMWH) anticoagulant widely used for the prevention and treatment of deep vein thrombosis (DVT), pulmonary embolism, and acute coronary syndrome. Mediocon Inc manufactures Enoxaparin Sodium API to IP/BP/EP/USP pharmacopoeial standards in its GMP-certified facility in Aurangabad, Maharashtra, India.
Our Enoxaparin Sodium API is supplied to injectable pharmaceutical manufacturers globally. It is one of the most widely used anticoagulants worldwide, and we provide full quality documentation and regulatory support for all markets.
Key Features
Applications
Why Choose Mediocon
| Parameter | Specification |
|---|---|
| Assay | NLT 98.0% |
| Loss on Drying | NMT 0.5% |
| Heavy Metals | NMT 20 ppm |
| Residue on Ignition | NMT 0.1% |
| Microbial Limits | Complies with pharmacopoeia |
| Identification | IR, HPLC Compliant |
| Packing | 25 kg HDPE drums / as per requirement |
Mediocon Inc is a GMP-certified API manufacturer and bulk pharmaceutical ingredient supplier based in Aurangabad, Maharashtra, India. We specialise in supplying Enoxaparin Sodium (CAS 679809-58-6) and over 1,000 other Active Pharmaceutical Ingredients, excipients, herbal extracts, and nutraceutical ingredients to pharmaceutical manufacturers worldwide.
Our Enoxaparin Sodium is manufactured under strict quality management protocols compliant with WHO-GMP, ISO 9001:2015, and major pharmacopoeial standards (IP, BP, USP, EP). Every batch undergoes full analytical testing — identity (IR/HPLC), assay, related substances, residual solvents (ICH Q3C), heavy metals, and microbial limits — before release with a Certificate of Analysis.
Export Markets
Quality & Compliance